LifeMD IncNASDAQ:LFMD
- LAST PRICE5.9100
- TODAY'S CHANGE (%)0.7800 (15.2047%)
- Bid / Lots5.9100/ 8
- Ask / Lots5.9300/ 6
- Open / Previous Close5.5000 / 5.1300
- Day Range
- 52 Week Range
- Volume511,020
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LFMD |
|---|---|---|
| 09:32 ET | 60272 | 5.65 |
| 09:33 ET | 46627 | 5.6 |
| 09:35 ET | 14486 | 5.6 |
| 09:37 ET | 45260 | 5.42 |
| 09:39 ET | 4018 | 5.3401 |
| 09:42 ET | 11305 | 5.46 |
| 09:44 ET | 8226 | 5.412 |
| 09:46 ET | 1761 | 5.44 |
| 09:48 ET | 55107 | 5.455 |
| 09:50 ET | 11985 | 5.46 |
| 09:51 ET | 24466 | 5.457069 |
| 09:53 ET | 19518 | 5.46 |
| 09:55 ET | 20418 | 5.46 |
| 09:57 ET | 37298 | 5.72 |
| 10:00 ET | 5188 | 5.79 |
| 10:02 ET | 19937 | 6.0455 |
| 10:04 ET | 22964 | 5.94 |
| 10:06 ET | 21737 | 5.795 |
| 10:08 ET | 8369 | 5.805 |
| 10:09 ET | 22642 | 5.8505 |
| 10:11 ET | 5443 | 5.938 |
| 10:13 ET | 803 | 5.91 |
Yesterday
LifeMD Reports Third Quarter 2024 Results, from 18 hours ago by Dow Jones
18 hours ago by Dow Jones
Nov 6, 2024
LifeMD(R) Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
Oct 24, 2024
Press Release: LifeMD(R) to Report Third Quarter 2024 Financial Results on November 7, from 8:00AM ET on Thursday Oct 24, 2024 by Dow Jones
8:00AM ET on Thursday Oct 24, 2024 by Dow JonesLifeMD(R) to Report Third Quarter 2024 Financial Results on November 7, from 8:00AM ET on Thursday Oct 24, 2024 by Dow Jones
8:00AM ET on Thursday Oct 24, 2024 by Dow Jones
Oct 23, 2024
LifeMD(R) Launches TestoRx, a New Rex MD(R) Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering, from 8:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
8:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
LifeMD Inc | 220.9M | -8.4x | --- |
Zynex Inc | 281.2M | 59.3x | +1.09% |
Outset Medical Inc | 40.4M | -0.3x | --- |
Harvard Bioscience Inc | 104.2M | -9.7x | --- |
AxoGen Inc | 581.6M | -33.6x | --- |
Akoya Biosciences Inc | 159.4M | -2.6x | --- |
Company Information
LifeMD, Inc. is a direct-to-patient telehealth company, which provides comprehensive virtual and in-home healthcare. The Company operates through two segments: Telehealth and WorkSimpli. Telehealth segment is engaged in telehealth platform, which integrates a clinician-centric electronic medical record (EMR) system, algorithms for case-load balancing and scheduling, customer relationship management functionality, asynchronous communication, secure synchronous, cloud pharmacy and more. Its technology platform, combined with its 50-state affiliated provider network, enables the management of virtual treatment offerings across various health conditions, including, dermatology, urgent and primary care, chronic care management, dermatology, chronic care management and other. Its WorkSimpli segment offers workplace and document services. This segment offers PDFSimpli an online software as a service platform that allows users to create, edit, convert, sign and share PDF documents.
Contact Information
- Headquarters
- 236 Fifth Avenue, Suite 400NEW YORK, NY, United States 10001
- Phone
- 914-244-1777
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Justin Schreiber
- Chief Financial Officer
- Marc Benathen
- Chief Operating Officer
- Brad Roberts
- Chief Technology Officer
- Dennis Wijnker
- Principal Accounting Officer, Controller
- Maria Stan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $220.9M |
|---|---|
Revenue (TTM) | $178.3M |
Shares Outstanding | 43.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.27 |
EPS | $-0.70 |
Book Value | $0.09 |
P/E Ratio | -8.4x |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
